Oliver Gray

Investing.com - Baird Equity Research has initiated coverage of SAGE Therapeutics Inc (NASDAQ:SAGE), assigning it a neutral rating with a price target of $15. Following the launch...

Investing.com - Analysts at Evercore Partners Inc (NYSE:EVR) recently provided a detailed look into the performance of the Chinese smartphone market, highlighting a second...

Investing.com - Analysts from Citigroup Inc (NYSE:C) have recently provided in-depth analysis on several Australian companies, highlighting potential market trends and...

Investing.com - Graincorp Ltd (ASX:GNC) released its H1 2024 results on Thursday, which align with the company's profit warning issued the previous week. The underlying EBITDA...

Investing.com - April's labour data continued its recent volatility on Thursday, as jobs growth rose more than expected while unemployment rose sharply. According to analysts from ...

Investing.com - Strategists at Morgan Stanley (NYSE:MS) Australia have recently evaluated the impact of the FY25 Australian Federal Budget on the country's equity market. The...

Investing.com - US stock futures indicated a largely unchanged opening on Sunday evening, coming on the heels of a week that saw the broader S&P 500 index setting new...

Investing.com - US stock futures experienced a slight decline on Thursday evening, following the S&P 500's near-miss of the historic 5,000 mark during intraday trading,...

Investing.com - US stock futures were trading in a tight range during Wednesday's evening deals, following a positive session for major benchmark indices as investors digested a...

Investing.com - US stock futures were trading in negative territory during Sunday's evening deals, following a mixed week for benchmark averages amid mixed inflation data and major...